Illumina showcases multi-omics potential to advance precision medicine in India
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
It supports sequencing-based COVID 19 surveillance in India
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Subscribe To Our Newsletter & Stay Updated